Comparative Clinical Pathology

, Volume 29, Issue 1, pp 33–41 | Cite as

A comparative study on the effects of vancomycin, enrofloxacin, and trimethoprim/sulfamethoxazole on methicillin-resistant Staphylococcus aureus osteomyelitis in an animal model

  • Ali Taghipour
  • Siamak Mashhadi RafieiEmail author
  • Mohammad Nasrollahzadeh Masouleh
  • Seyed Pejman Mortazavi
Original Article


Osteomyelitis is a serious medical issue that is refractory to treatments. Methicillin-resistant Staphylococcus aureus (MRSA) is a major problem in cases with osteomyelitis. These S. aureus have recently developed a resistance to vancomycin, which is a choice antibiotic for osteomyelitis. Therefore, finding alternative antibiotics is highly essential for treatment of methicillin-resistant S. aureus osteomyelitis. Twenty-four New Zealand adult white rabbits were experimentally infected by the injection of 106 colony-forming unit of Staphylococcus aureus in diaphysis of the tibia. Two weeks after injection, the animals were checked by microbiological and radiological tests for osteomyelitis. All infected rabbits were randomly divided into four groups of 6 including control, vancomycin, enrofloxacin, and trimethoprim/sulfamethoxazole, and every 12 h were administered with 30, 15, and 20 mg/kg, for treatment groups, respectively. Body weight, body temperature, and heterophil/lymphocyte ratio were assessed before and after inducing osteomyelitis. Then, the animals were treated in experimental groups for 2 weeks post infection. All of the experiment and control groups were humanely sacrificed. Subsequently, the bone specimens were separated for microbiological tests. The groups treated with vancomycin and enrofloxacin had significantly lower colony counts, and lower heterophil/lymphocyte ratio than control groups after treatment (P < 0.05). In this study, enrofloxacin had comparable efficacy to that of the vancomycin-treated group. However, trimethoprim/sulfamethoxazole did not show such efficacy. It can be inferred that enrofloxacin can be an effective antibiotic for the treatment of acute osteomyelitis caused by methicillin-resistant Staphylococcus aureus.


Osteomyelitis Methicillin-resistant Staphylococcus aureus Vancomycin Enrofloxacin Trimethoprim/sulfamethoxazole 



This study was funded by the Faculty of Veterinary Medicine, Azad Islamic University, Iran.

Compliance with ethical standards

Conflict of interest

The author Dr. Siamak Mashhadi Rafiei has received research grants from Faculty of Specialized Veterinary Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.


  1. Adra M, Lawrence KR (2004) Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother 38:338–341CrossRefGoogle Scholar
  2. Ahaduzzaman M, Hassan MM, Alam M, Islam SKMA, Uddin I (2014) Antimicrobial resistance pattern against Staphylococcus aureus in environmental effluents. Res J Vet Pract 2(1):13–16CrossRefGoogle Scholar
  3. Anwar H, Dasgupta M, Costerton J (1990) Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother 34(11):2043–2046CrossRefGoogle Scholar
  4. Castellazzi L, Mantero M, Esposito S (2016) Update on the management of pediatric acute osteomyelitis and septic arthritis. Int J Mol Sci 17(6):855CrossRefGoogle Scholar
  5. Claeys KC, Smith JR, Casapao AM, Mynatt RP, Avery L, Shroff A, Yamamura D, Davis SL, Rybak MJ (2015) Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 59(4):1969–1976CrossRefGoogle Scholar
  6. Dellamonica P, Bernard E, Etesse H, Garraffo R, Drugeon HB (1989) Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. Eur J Clin Microbiol 8(12):1024–1030CrossRefGoogle Scholar
  7. Elwell LP, Wilson HR, Knick VB, Keith BR (1986) In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 29(6):1092–1094CrossRefGoogle Scholar
  8. Flecknell PA (2000) BSAVA manual of rabbit medicine and surgery. British Small Animal Veterinary Association, pp 95–98Google Scholar
  9. Godley DR (2015) Managing musculoskeletal infections in children in the era of increasing bacterial resistance. JAAP 28(4):24–29CrossRefGoogle Scholar
  10. Goldstein EJ, Proctor RA (2008) Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46(4):584–593CrossRefGoogle Scholar
  11. Griffon D, Hamaide A (2016) Complications in small animal surgery. Wiley, pp 28–29Google Scholar
  12. Grohs P, Kitzis MD, Gutmann L (2003) In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother 47(1):418–420CrossRefGoogle Scholar
  13. Hackbarth CJ, Chambers HF (1989) Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrob Agents Chemother 33(7):995–999CrossRefGoogle Scholar
  14. Howe RA, Bowker KE, Walsh TR, Feest TG, MacGowan AP (1998) Vancomycin-resistant Staphylococcus aureus. Lancet 351(9102):602CrossRefGoogle Scholar
  15. Markey B, Leonard F, Archambault M, Cullinane A, Maguire D (2013) Clinical veterinary microbiology e-book. Elsevier Health Sciences, pp 105–117Google Scholar
  16. Markowitz N, Quinn EL, Saravolatz LD (1992) Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 117(5):390–397CrossRefGoogle Scholar
  17. Meredith A (2015) BSAVA small animal formulary: part B: exotic pets. Wiley, pp 115–116Google Scholar
  18. Messina AF, Namtu K, Guild M, Dumois JA, Berman DM (2011) Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis. Pediatr Infect Dis J 30(12):1019–1021CrossRefGoogle Scholar
  19. Olson EJ, Carlson CS (2017) Chapter 16—bones, joints, tendons, and ligaments1 A2 – Zachary. In: James F (ed). Pathologic basis of veterinary disease (6th edn), Mosby, p 983Google Scholar
  20. Owen M, Moores A, Coe R (2004) Management of MRSA septic arthritis in a dog using a gentamicin-impregnated collagen sponge. J Small Anim Pract 45(12):609–612CrossRefGoogle Scholar
  21. Paul I, Isore DP, Joardar SN, Mukhopadhayay SK, Ganguly S, Pal S (2013) Bacteriological investigation and antibiogram on methicillin-resistant Staphylococcus aureus (MRSA) causing subclinical mastitis in dairy cattle population of West Bengal. Indian J Comp Microbiol Immunol Infect Dis 34(2):56–59Google Scholar
  22. Plumb D (2011) Plumb’s veterinary drug handbook, 7th edn. Wiley-Blackwell, Ames, pp 464–1160Google Scholar
  23. Ratnayake K, Davis AJ, Brown L, Young TP (2015) Pediatric acute osteomyelitis in the postvaccine, methicillin-resistant Staphylococcus aureus era. Am J Emerg Med 33(10):1420–1424CrossRefGoogle Scholar
  24. Rubin JE, Ball KR, Chirino-Trejo M (2011) Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus pseudintermedius isolated from various animals. Canadian. Vet J 52(2):153Google Scholar
  25. Siqueira EGM, Rahal SC, Ribeiro MG, Paes AC, Listoni FP, Vassalo FG (2014) Exogenous bacterial osteomyelitis in 52 dogs: a retrospective study of etiology and in vitro antimicrobial susceptibility profile (2000–2013). Vet Q 34(4):201–204CrossRefGoogle Scholar
  26. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant–related staphylococcal infections: a randomized controlled trial. JAMA 279(19):1537–1541CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Small Animal Medicine and Radiology, Faculty of Specialized Veterinary Sciences, Science and Research BranchIslamic Azad UniversityTehranIran
  2. 2.Department of Pathology and Clinical Pathology, Faculty of Specialized Veterinary Sciences, Science and Research BranchIslamic Azad UniversityTehranIran

Personalised recommendations